Transgenic Goats Produced by Germ Cell Transplantation

Information

  • Research Project
  • 6645227
  • ApplicationId
    6645227
  • Core Project Number
    R41HD044780
  • Full Project Number
    1R41HD044780-01
  • Serial Number
    44780
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/2003 - 21 years ago
  • Project End Date
    11/30/2004 - 20 years ago
  • Program Officer Name
    GRIEDER, FRANZISKA B
  • Budget Start Date
    4/1/2003 - 21 years ago
  • Budget End Date
    11/30/2004 - 20 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
  • Award Notice Date
    -
Organizations

Transgenic Goats Produced by Germ Cell Transplantation

[unreadable] DESCRIPTION (provided by applicant): The objective of this proposal is to optimize methods of male germ cell transfection and transplantation for use in producing transgenic goats. The milk of transgenic goats is a safe, abundant and cost effective production source for recombinant human biopharmaceuticals. GTC Biotherapeutics (formerly Genzyme Transgenics Corp.) has nearly two dozen commercial transgenic programs in development. However, even state-of-the-art methods for generating transgenic founder (first generation) goats remain relatively inefficient and expensive. Methods have been developed in rodents for transplanting genetically modified male germ cells into recipient males and mating these animals to produce transgenic offspring. A similar system has shown some early success in pigs, and preliminary studies suggest that it may be feasible in goats. Now we propose to: 1) optimize methods of enriching donor germ cell preparations; 2) optimize methods of transfecting transgene constructs into these donor cells in vitro; and 3) confirm that homologous germ cell transplantation in goats results in the production of morphologically normal, motile sperm carrying the transgene. If this approach is successful, it will increase the efficiency and reduce the cost of generating founder animals, which is a critical early step in the transgenic production process. [unreadable] [unreadable]

IC Name
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT
  • Activity
    R41
  • Administering IC
    HD
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    865
  • Ed Inst. Type
  • Funding ICs
    NICHD:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    GTC BIOTHERAPEUTICS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    FRAMINGHAM
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01702
  • Organization District
    UNITED STATES